vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and PAMT CORP (PAMT). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $141.3M, roughly 1.5× PAMT CORP). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -20.7%, a 23.4% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -15.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-25.0M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -12.0%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

IRTC vs PAMT — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.5× larger
IRTC
$208.9M
$141.3M
PAMT
Growing faster (revenue YoY)
IRTC
IRTC
+42.3% gap
IRTC
27.1%
-15.1%
PAMT
Higher net margin
IRTC
IRTC
23.4% more per $
IRTC
2.7%
-20.7%
PAMT
More free cash flow
IRTC
IRTC
$39.5M more FCF
IRTC
$14.5M
$-25.0M
PAMT
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRTC
IRTC
PAMT
PAMT
Revenue
$208.9M
$141.3M
Net Profit
$5.6M
$-29.3M
Gross Margin
70.9%
Operating Margin
1.1%
-27.0%
Net Margin
2.7%
-20.7%
Revenue YoY
27.1%
-15.1%
Net Profit YoY
518.5%
7.4%
EPS (diluted)
$0.18
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
PAMT
PAMT
Q4 25
$208.9M
$141.3M
Q3 25
$192.9M
$150.3M
Q2 25
$186.7M
$151.1M
Q1 25
$158.7M
$155.3M
Q4 24
$164.3M
$166.5M
Q3 24
$147.5M
$182.6M
Q2 24
$148.0M
$182.9M
Q1 24
$131.9M
$182.6M
Net Profit
IRTC
IRTC
PAMT
PAMT
Q4 25
$5.6M
$-29.3M
Q3 25
$-5.2M
$-5.6M
Q2 25
$-14.2M
$-9.6M
Q1 25
$-30.7M
$-8.1M
Q4 24
$-1.3M
$-31.6M
Q3 24
$-46.2M
$2.4M
Q2 24
$-20.1M
$-2.9M
Q1 24
$-45.7M
$281.0K
Gross Margin
IRTC
IRTC
PAMT
PAMT
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
IRTC
IRTC
PAMT
PAMT
Q4 25
1.1%
-27.0%
Q3 25
-4.4%
-3.8%
Q2 25
-10.0%
-7.3%
Q1 25
-20.5%
-5.9%
Q4 24
-2.5%
-22.6%
Q3 24
-34.1%
1.3%
Q2 24
-15.5%
-0.4%
Q1 24
-28.9%
-0.4%
Net Margin
IRTC
IRTC
PAMT
PAMT
Q4 25
2.7%
-20.7%
Q3 25
-2.7%
-3.7%
Q2 25
-7.6%
-6.4%
Q1 25
-19.3%
-5.2%
Q4 24
-0.8%
-19.0%
Q3 24
-31.3%
1.3%
Q2 24
-13.6%
-1.6%
Q1 24
-34.6%
0.2%
EPS (diluted)
IRTC
IRTC
PAMT
PAMT
Q4 25
$0.18
$-1.38
Q3 25
$-0.16
$-0.27
Q2 25
$-0.44
$-0.46
Q1 25
$-0.97
$-0.37
Q4 24
$-0.03
$-1.44
Q3 24
$-1.48
$0.11
Q2 24
$-0.65
$-0.13
Q1 24
$-1.47
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$583.8M
$83.7M
Total DebtLower is stronger
$333.9M
Stockholders' EquityBook value
$152.7M
$210.5M
Total Assets
$1.0B
$697.9M
Debt / EquityLower = less leverage
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
PAMT
PAMT
Q4 25
$583.8M
$83.7M
Q3 25
$565.2M
$115.6M
Q2 25
$545.5M
$117.3M
Q1 25
$520.6M
$102.7M
Q4 24
$535.6M
$110.7M
Q3 24
$522.0M
$92.3M
Q2 24
$561.5M
$114.0M
Q1 24
$569.1M
$125.8M
Total Debt
IRTC
IRTC
PAMT
PAMT
Q4 25
$333.9M
Q3 25
Q2 25
Q1 25
Q4 24
$325.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IRTC
IRTC
PAMT
PAMT
Q4 25
$152.7M
$210.5M
Q3 25
$121.9M
$239.5M
Q2 25
$103.7M
$244.9M
Q1 25
$86.7M
$269.6M
Q4 24
$90.9M
$277.5M
Q3 24
$71.8M
$308.9M
Q2 24
$99.2M
$306.7M
Q1 24
$90.3M
$314.6M
Total Assets
IRTC
IRTC
PAMT
PAMT
Q4 25
$1.0B
$697.9M
Q3 25
$995.2M
$715.2M
Q2 25
$964.0M
$707.9M
Q1 25
$926.1M
$712.6M
Q4 24
$931.4M
$741.7M
Q3 24
$909.7M
$756.7M
Q2 24
$919.2M
$733.5M
Q1 24
$909.8M
$746.4M
Debt / Equity
IRTC
IRTC
PAMT
PAMT
Q4 25
1.59×
Q3 25
Q2 25
Q1 25
Q4 24
1.17×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
PAMT
PAMT
Operating Cash FlowLast quarter
$26.2M
$-5.8M
Free Cash FlowOCF − Capex
$14.5M
$-25.0M
FCF MarginFCF / Revenue
6.9%
-17.7%
Capex IntensityCapex / Revenue
5.6%
13.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
PAMT
PAMT
Q4 25
$26.2M
$-5.8M
Q3 25
$34.9M
$5.9M
Q2 25
$27.7M
$12.2M
Q1 25
$-7.9M
$5.0M
Q4 24
$19.2M
$15.2M
Q3 24
$24.3M
$15.5M
Q2 24
$11.8M
$18.7M
Q1 24
$-52.0M
$9.6M
Free Cash Flow
IRTC
IRTC
PAMT
PAMT
Q4 25
$14.5M
$-25.0M
Q3 25
$20.1M
$2.5M
Q2 25
$17.3M
$5.9M
Q1 25
$-17.3M
$-6.8M
Q4 24
$12.4M
$-39.9M
Q3 24
$15.5M
$-33.6M
Q2 24
$3.4M
$4.1M
Q1 24
$-61.8M
$-12.2M
FCF Margin
IRTC
IRTC
PAMT
PAMT
Q4 25
6.9%
-17.7%
Q3 25
10.4%
1.7%
Q2 25
9.3%
3.9%
Q1 25
-10.9%
-4.4%
Q4 24
7.5%
-24.0%
Q3 24
10.5%
-18.4%
Q2 24
2.3%
2.2%
Q1 24
-46.8%
-6.7%
Capex Intensity
IRTC
IRTC
PAMT
PAMT
Q4 25
5.6%
13.6%
Q3 25
7.7%
2.3%
Q2 25
5.6%
4.2%
Q1 25
5.9%
7.6%
Q4 24
4.2%
33.1%
Q3 24
6.0%
26.9%
Q2 24
5.7%
8.0%
Q1 24
7.4%
12.0%
Cash Conversion
IRTC
IRTC
PAMT
PAMT
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
6.44×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons